GSK’s long-acting injection beats Truvada in HIV prevention trial
Truvada generated $2.8 billion in sales last year, both from treatment and preventing an HIV infection
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Truvada
FDA approves second drug to prevent HIV infection as part of ongoing efforts to end the HIV epidemic
Descovy, the drug, is not indicated in individuals at risk of HIV-1 infection from receptive vaginal sex because the effectivness…